Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 157 to 168 of 168 entries
Sorted by: Best Match Show Resources per page
Effectiveness of structured education and training in perineal wound assessment and repair for midwives and midwifery students: A review of the literature.

European journal of midwifery

Diaz MP, Simpson N, Brown A, Diorgu FC, Steen M.
PMID: 34046559
Eur J Midwifery. 2021 May 20;5:13. doi: 10.18332/ejm/134511. eCollection 2021.

INTRODUCTION: Perineal trauma is a commonly observed complication of childbirth, affecting more than 75% of women who have a vaginal birth. Perineal trauma is associated with significant short- and long-term comorbidities that negatively impact women's quality of life. Severe...

Cite
Diaz MP, Simpson N, Brown A, et al. Effectiveness of structured education and training in perineal wound assessment and repair for midwives and midwifery students: A review of the literature. Eur J Midwifery. 2021;5:13doi: 10.18332/ejm/134511.
Diaz, M. P., Simpson, N., Brown, A., Diorgu, F. C., & Steen, M. (2021). Effectiveness of structured education and training in perineal wound assessment and repair for midwives and midwifery students: A review of the literature. European journal of midwifery, 513. https://doi.org/10.18332/ejm/134511
Diaz, Monica P, et al. "Effectiveness of structured education and training in perineal wound assessment and repair for midwives and midwifery students: A review of the literature." European journal of midwifery vol. 5 (2021): 13. doi: https://doi.org/10.18332/ejm/134511
Diaz MP, Simpson N, Brown A, Diorgu FC, Steen M. Effectiveness of structured education and training in perineal wound assessment and repair for midwives and midwifery students: A review of the literature. Eur J Midwifery. 2021 May 20;5:13. doi: 10.18332/ejm/134511. eCollection 2021. PMID: 34046559; PMCID: PMC8135602.
Copy Download .nbib Format: NLM
Disseminated-cutaneous sporotrichosis in an immunocompetent adult.

JAAD case reports

Garcia BM, Bond AR, Barry AK, Steen AJ, LeBoit PE, Ashbaugh C, Shinkai K.
PMID: 33948469
JAAD Case Rep. 2021 Mar 26;11:102-104. doi: 10.1016/j.jdcr.2021.03.003. eCollection 2021 May.

No abstract available.

Cite
Garcia BM, Bond AR, Barry AK, et al. Disseminated-cutaneous sporotrichosis in an immunocompetent adult. JAAD Case Rep. 2021;11:102-104doi: 10.1016/j.jdcr.2021.03.003.
Garcia, B. M., Bond, A. R., Barry, A. K., Steen, A. J., LeBoit, P. E., Ashbaugh, C., & Shinkai, K. (2021). Disseminated-cutaneous sporotrichosis in an immunocompetent adult. JAAD case reports, 11102-104. https://doi.org/10.1016/j.jdcr.2021.03.003
Garcia, Briana M, et al. "Disseminated-cutaneous sporotrichosis in an immunocompetent adult." JAAD case reports vol. 11 (2021): 102-104. doi: https://doi.org/10.1016/j.jdcr.2021.03.003
Garcia BM, Bond AR, Barry AK, Steen AJ, LeBoit PE, Ashbaugh C, Shinkai K. Disseminated-cutaneous sporotrichosis in an immunocompetent adult. JAAD Case Rep. 2021 Mar 26;11:102-104. doi: 10.1016/j.jdcr.2021.03.003. eCollection 2021 May. PMID: 33948469; PMCID: PMC8079824.
Copy Download .nbib Format: NLM
Neuronal current imaging: An experimental method to investigate electrical currents in dogs with idiopathic epilepsy.

Journal of veterinary internal medicine

Unger DM, Wiest R, Kiefer C, Raillard M, Dutil GF, Stein VM, Schweizer D.
PMID: 34623697
J Vet Intern Med. 2021 Oct 08; doi: 10.1111/jvim.16270. Epub 2021 Oct 08.

BACKGROUND: The diagnosis of idiopathic epilepsy (IE) in dogs is based on exclusion of other potential causes of seizures. Recently, a novel magnetic resonance imaging (MRI) sequence that utilizes a variant of the rotary saturation approach has been suggested...

Cite
Unger DM, Wiest R, Kiefer C, et al. Neuronal current imaging: An experimental method to investigate electrical currents in dogs with idiopathic epilepsy. J Vet Intern Med. 2021;doi: 10.1111/jvim.16270.
Unger, D. M., Wiest, R., Kiefer, C., Raillard, M., Dutil, G. F., Stein, V. M., & Schweizer, D. (2021). Neuronal current imaging: An experimental method to investigate electrical currents in dogs with idiopathic epilepsy. Journal of veterinary internal medicine, . https://doi.org/10.1111/jvim.16270
Unger, Daniela M, et al. "Neuronal current imaging: An experimental method to investigate electrical currents in dogs with idiopathic epilepsy." Journal of veterinary internal medicine vol. (2021). doi: https://doi.org/10.1111/jvim.16270
Unger DM, Wiest R, Kiefer C, Raillard M, Dutil GF, Stein VM, Schweizer D. Neuronal current imaging: An experimental method to investigate electrical currents in dogs with idiopathic epilepsy. J Vet Intern Med. 2021 Oct 08; doi: 10.1111/jvim.16270. Epub 2021 Oct 08. PMID: 34623697.
Copy Download .nbib Format: NLM
Potential Activities and Long Lifetimes of Organic Carbon-Degrading Extracellular Enzymes in Deep Subsurface Sediments of the Baltic Sea.

Frontiers in microbiology

Schmidt JM, Royalty TM, Lloyd KG, Steen AD.
PMID: 34603228
Front Microbiol. 2021 Sep 17;12:702015. doi: 10.3389/fmicb.2021.702015. eCollection 2021.

Heterotrophic microorganisms in marine sediments produce extracellular enzymes to hydrolyze organic macromolecules, so their products can be transported inside the cell and used for energy and growth. Therefore, extracellular enzymes may mediate the fate of organic carbon in sediments....

Cite
Schmidt JM, Royalty TM, Lloyd KG, et al. Potential Activities and Long Lifetimes of Organic Carbon-Degrading Extracellular Enzymes in Deep Subsurface Sediments of the Baltic Sea. Front Microbiol. 2021;12:702015doi: 10.3389/fmicb.2021.702015.
Schmidt, J. M., Royalty, T. M., Lloyd, K. G., & Steen, A. D. (2021). Potential Activities and Long Lifetimes of Organic Carbon-Degrading Extracellular Enzymes in Deep Subsurface Sediments of the Baltic Sea. Frontiers in microbiology, 12702015. https://doi.org/10.3389/fmicb.2021.702015
Schmidt, Jenna M, et al. "Potential Activities and Long Lifetimes of Organic Carbon-Degrading Extracellular Enzymes in Deep Subsurface Sediments of the Baltic Sea." Frontiers in microbiology vol. 12 (2021): 702015. doi: https://doi.org/10.3389/fmicb.2021.702015
Schmidt JM, Royalty TM, Lloyd KG, Steen AD. Potential Activities and Long Lifetimes of Organic Carbon-Degrading Extracellular Enzymes in Deep Subsurface Sediments of the Baltic Sea. Front Microbiol. 2021 Sep 17;12:702015. doi: 10.3389/fmicb.2021.702015. eCollection 2021. PMID: 34603228; PMCID: PMC8485070.
Copy Download .nbib Format: NLM
Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry.

Rheumatology (Oxford, England)

Showalter K, Pinheiro LC, Jannat-Khah D, Sobol I, Szymonifka J, Finik J, Steen VD, Gordon JK.
PMID: 34273167
Rheumatology (Oxford). 2021 Jul 17; doi: 10.1093/rheumatology/keab569. Epub 2021 Jul 17.

OBJECTIVE: To identify individual-level factors associated with hospital readmission among individuals with systemic sclerosis associated pulmonary hypertension (SSc-PH).METHODS: Individuals enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) registry contributed clinical data related to SSc-PH...

Cite
Showalter K, Pinheiro LC, Jannat-Khah D, et al. Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab569.
Showalter, K., Pinheiro, L. C., Jannat-Khah, D., Sobol, I., Szymonifka, J., Finik, J., Steen, V. D., & Gordon, J. K. (2021). Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab569
Showalter, Kimberly, et al. "Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab569
Showalter K, Pinheiro LC, Jannat-Khah D, Sobol I, Szymonifka J, Finik J, Steen VD, Gordon JK. Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry. Rheumatology (Oxford). 2021 Jul 17; doi: 10.1093/rheumatology/keab569. Epub 2021 Jul 17. PMID: 34273167.
Copy Download .nbib Format: NLM
Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation.

Brain, behavior, and immunity

Szabo A, O'Connell KS, Ueland T, Sheikh MA, Agartz I, Andreou D, Aukrust P, Boye B, Bøen E, Drange OK, Elvsåshagen T, Engh JA, Hope S, Collier Høegh M, Joa I, Johnsen E, Kroken RA, Vik Lagerberg T, Lekva T, Malt UF, Melle I, Morken G, Nærland T, Steen VM, Sørensen K, Wedervang-Resell K, Auten Weibell M, Westlye LT, Steen NE, Andreassen O, Djurovic S.
PMID: 34758379
Brain Behav Immun. 2022 Jan;99:299-306. doi: 10.1016/j.bbi.2021.10.017. Epub 2021 Nov 07.

BACKGROUND: Schizophrenia (SCZ) and bipolar disorder (BD) are severe mental illnesses (SMI) that are part of a psychosis continuum, and dysregulated innate immune responses have been suggested to be involved in their pathophysiology. However, disease-specific immune mechanisms in SMI...

Cite
Szabo A, O'Connell KS, Ueland T, et al. Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain Behav Immun. 2021;99:299-306doi: 10.1016/j.bbi.2021.10.017.
Szabo, A., O'Connell, K. S., Ueland, T., Sheikh, M. A., Agartz, I., Andreou, D., Aukrust, P., Boye, B., Bøen, E., Drange, O. K., Elvsåshagen, T., Engh, J. A., Hope, S., Collier Høegh, M., Joa, I., Johnsen, E., Kroken, R. A., Vik Lagerberg, T., Lekva, T., Malt, U. F., Melle, I., Morken, G., Nærland, T., Steen, V. M., Sørensen, K., Wedervang-Resell, K., Auten Weibell, M., Westlye, L. T., Steen, N. E., Andreassen, O., & Djurovic, S. (2022). Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain, behavior, and immunity, 99299-306. https://doi.org/10.1016/j.bbi.2021.10.017
Szabo, Attila, et al. "Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation." Brain, behavior, and immunity vol. 99 (2022): 299-306. doi: https://doi.org/10.1016/j.bbi.2021.10.017
Szabo A, O'Connell KS, Ueland T, Sheikh MA, Agartz I, Andreou D, Aukrust P, Boye B, Bøen E, Drange OK, Elvsåshagen T, Engh JA, Hope S, Collier Høegh M, Joa I, Johnsen E, Kroken RA, Vik Lagerberg T, Lekva T, Malt UF, Melle I, Morken G, Nærland T, Steen VM, Sørensen K, Wedervang-Resell K, Auten Weibell M, Westlye LT, Steen NE, Andreassen O, Djurovic S. Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation. Brain Behav Immun. 2022 Jan;99:299-306. doi: 10.1016/j.bbi.2021.10.017. Epub 2021 Nov 07. PMID: 34758379.
Copy Download .nbib Format: NLM
Healthy eating in pregnancy, education for midwives: A pre-post intervention study.

European journal of midwifery

Othman SME, Steen M, Fleet JA, Jayasekara R.
PMID: 33537622
Eur J Midwifery. 2020 May 20;4:20. doi: 10.18332/ejm/120004. eCollection 2020.

INTRODUCTION: Midwives have an important role in providing education in healthy eating to pregnant women, which is essential for maternal and foetal health and wellbeing. Importantly, midwives require continual professional development to ensure they provide up-to-date education.METHODS: A pre-post...

Cite
Othman SME, Steen M, Fleet JA, et al. Healthy eating in pregnancy, education for midwives: A pre-post intervention study. Eur J Midwifery. 2020;4:20doi: 10.18332/ejm/120004.
Othman, S. M. E., Steen, M., Fleet, J. A., & Jayasekara, R. (2020). Healthy eating in pregnancy, education for midwives: A pre-post intervention study. European journal of midwifery, 420. https://doi.org/10.18332/ejm/120004
Othman, Shwikar M E, et al. "Healthy eating in pregnancy, education for midwives: A pre-post intervention study." European journal of midwifery vol. 4 (2020): 20. doi: https://doi.org/10.18332/ejm/120004
Othman SME, Steen M, Fleet JA, Jayasekara R. Healthy eating in pregnancy, education for midwives: A pre-post intervention study. Eur J Midwifery. 2020 May 20;4:20. doi: 10.18332/ejm/120004. eCollection 2020. PMID: 33537622; PMCID: PMC7839119.
Copy Download .nbib Format: NLM
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.

Rheumatology (Oxford, England)

Domsic RT, Gao S, Laffoon M, Wisniewski S, Zhang Y, Steen V, Lafyatis R, Medsger TA.
PMID: 33506859
Rheumatology (Oxford). 2021 Oct 02;60(10):4662-4670. doi: 10.1093/rheumatology/keab075.

OBJECTIVES: Clinical trials in early diffuse cutaneous systemic sclerosis (SSc) using the modified Rodnan skin score (mRSS) as the primary outcome measure have most often been negative. We wanted to assess how the definition of disease onset (first SSc...

Cite
Domsic RT, Gao S, Laffoon M, et al. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford). 2021;60(10):4662-4670doi: 10.1093/rheumatology/keab075.
Domsic, R. T., Gao, S., Laffoon, M., Wisniewski, S., Zhang, Y., Steen, V., Lafyatis, R., & Medsger, T. A. (2021). Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford, England), 60(10), 4662-4670. https://doi.org/10.1093/rheumatology/keab075
Domsic, Robyn T, et al. "Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design." Rheumatology (Oxford, England) vol. 60,10 (2021): 4662-4670. doi: https://doi.org/10.1093/rheumatology/keab075
Domsic RT, Gao S, Laffoon M, Wisniewski S, Zhang Y, Steen V, Lafyatis R, Medsger TA. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford). 2021 Oct 02;60(10):4662-4670. doi: 10.1093/rheumatology/keab075. PMID: 33506859.
Copy Download .nbib Format: NLM
Independent Evolution of a Lysergic Acid Amide in Aspergillus Species.

Applied and environmental microbiology

Jones AM, Steen CR, Panaccione DG.
PMID: 34586904
Appl Environ Microbiol. 2021 Nov 24;87(24):e0180121. doi: 10.1128/AEM.01801-21. Epub 2021 Sep 29.

Ergot alkaloids derived from lysergic acid have impacted humanity as contaminants of crops and as the bases of pharmaceuticals prescribed to treat dementia, migraines, and other disorders. Several plant-associated fungi in the Clavicipitaceae produce lysergic acid derivatives, but many...

Cite
Jones AM, Steen CR, Panaccione DG. Independent Evolution of a Lysergic Acid Amide in Aspergillus Species. Appl Environ Microbiol. 2021;87(24):e0180121doi: 10.1128/AEM.01801-21.
Jones, A. M., Steen, C. R., & Panaccione, D. G. (2021). Independent Evolution of a Lysergic Acid Amide in Aspergillus Species. Applied and environmental microbiology, 87(24), e0180121. https://doi.org/10.1128/AEM.01801-21
Jones, Abigail M, et al. "Independent Evolution of a Lysergic Acid Amide in Aspergillus Species." Applied and environmental microbiology vol. 87,24 (2021): e0180121. doi: https://doi.org/10.1128/AEM.01801-21
Jones AM, Steen CR, Panaccione DG. Independent Evolution of a Lysergic Acid Amide in Aspergillus Species. Appl Environ Microbiol. 2021 Nov 24;87(24):e0180121. doi: 10.1128/AEM.01801-21. Epub 2021 Sep 29. PMID: 34586904; PMCID: PMC8612279.
Copy Download .nbib Format: NLM
Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group.

Journal of the Formosan Medical Association = Taiwan yi zhi

Ho WL, Hung GY, Yen HJ, Yang YL, Chang HH, Lu MY, Lin KH, Chen JS, Cheng CN, Hung IJ, Yang CP, Chen SH, Liu HC, Yeh TC, Hou JY, Hsiao CC, Sheen JM, Chang TT, Wong TT, Miser JS, Liu YL, Chen RL, Chen BW, Peng CT, Chang TK, Wu KH, Chang YH, Wang JL, Wang SC, Lin MT, Hu FC, Jou ST, Lin DT.
PMID: 34154895
J Formos Med Assoc. 2022 Jan;121(1):350-359. doi: 10.1016/j.jfma.2021.05.012. Epub 2021 Jun 18.

BACKGROUND: Patients with childhood cancer are at increased risk for the development of second cancers.METHODS: A national multicenter survey of second cancers conducted by the Taiwan Pediatric Oncology Group retrieved retrospective data from the database at the Children Cancer...

Cite
Ho WL, Hung GY, Yen HJ, et al. Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group. J Formos Med Assoc. 2021;121(1):350-359doi: 10.1016/j.jfma.2021.05.012.
Ho, W. L., Hung, G. Y., Yen, H. J., Yang, Y. L., Chang, H. H., Lu, M. Y., Lin, K. H., Chen, J. S., Cheng, C. N., Hung, I. J., Yang, C. P., Chen, S. H., Liu, H. C., Yeh, T. C., Hou, J. Y., Hsiao, C. C., Sheen, J. M., Chang, T. T., Wong, T. T., Miser, J. S., Liu, Y. L., Chen, R. L., Chen, B. W., Peng, C. T., Chang, T. K., Wu, K. H., Chang, Y. H., Wang, J. L., Wang, S. C., Lin, M. T., Hu, F. C., Jou, S. T., & Lin, D. T. (2022). Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group. Journal of the Formosan Medical Association = Taiwan yi zhi, 121(1), 350-359. https://doi.org/10.1016/j.jfma.2021.05.012
Ho, Wan-Ling, et al. "Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group." Journal of the Formosan Medical Association = Taiwan yi zhi vol. 121,1 (2022): 350-359. doi: https://doi.org/10.1016/j.jfma.2021.05.012
Ho WL, Hung GY, Yen HJ, Yang YL, Chang HH, Lu MY, Lin KH, Chen JS, Cheng CN, Hung IJ, Yang CP, Chen SH, Liu HC, Yeh TC, Hou JY, Hsiao CC, Sheen JM, Chang TT, Wong TT, Miser JS, Liu YL, Chen RL, Chen BW, Peng CT, Chang TK, Wu KH, Chang YH, Wang JL, Wang SC, Lin MT, Hu FC, Jou ST, Lin DT. Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group. J Formos Med Assoc. 2022 Jan;121(1):350-359. doi: 10.1016/j.jfma.2021.05.012. Epub 2021 Jun 18. PMID: 34154895.
Copy Download .nbib Format: NLM
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.

Rheumatology (Oxford, England)

Domsic RT, Gao S, Laffoon M, Wisniewski S, Zhang Y, Steen V, Lafyatis R, Medsger TA.
PMID: 33506859
Rheumatology (Oxford). 2021 Oct 02;60(10):4662-4670. doi: 10.1093/rheumatology/keab075.

OBJECTIVES: Clinical trials in early diffuse cutaneous systemic sclerosis (SSc) using the modified Rodnan skin score (mRSS) as the primary outcome measure have most often been negative. We wanted to assess how the definition of disease onset (first SSc...

Cite
Domsic RT, Gao S, Laffoon M, et al. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford). 2021;60(10):4662-4670doi: 10.1093/rheumatology/keab075.
Domsic, R. T., Gao, S., Laffoon, M., Wisniewski, S., Zhang, Y., Steen, V., Lafyatis, R., & Medsger, T. A. (2021). Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford, England), 60(10), 4662-4670. https://doi.org/10.1093/rheumatology/keab075
Domsic, Robyn T, et al. "Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design." Rheumatology (Oxford, England) vol. 60,10 (2021): 4662-4670. doi: https://doi.org/10.1093/rheumatology/keab075
Domsic RT, Gao S, Laffoon M, Wisniewski S, Zhang Y, Steen V, Lafyatis R, Medsger TA. Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design. Rheumatology (Oxford). 2021 Oct 02;60(10):4662-4670. doi: 10.1093/rheumatology/keab075. PMID: 33506859; PMCID: PMC8677444.
Copy Download .nbib Format: NLM
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II.

ACR open rheumatology

Volkmann ER, Steen V, Li N, Roth MD, Clements PJ, Furst DE, Assassi S, Khanna D, Kim GJ, Goldin J, Elashoff RM, Tashkin DP.
PMID: 33277978
ACR Open Rheumatol. 2021 Jan;3(1):8-16. doi: 10.1002/acr2.11206. Epub 2020 Dec 05.

OBJECTIVE: To evaluate short- and long-term outcomes of African American (AA) participants of Scleroderma Lung Studies (SLS) I and II.METHODS: SLS I randomized 158 participants with systemic sclerosis-interstitial lung disease (SSc-ILD) to 1 year of oral cyclophosphamide (CYC) versus...

Cite
Volkmann ER, Steen V, Li N, et al. Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II. ACR Open Rheumatol. 2020;3(1):8-16doi: 10.1002/acr2.11206.
Volkmann, E. R., Steen, V., Li, N., Roth, M. D., Clements, P. J., Furst, D. E., Assassi, S., Khanna, D., Kim, G. J., Goldin, J., Elashoff, R. M., & Tashkin, D. P. (2021). Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II. ACR open rheumatology, 3(1), 8-16. https://doi.org/10.1002/acr2.11206
Volkmann, Elizabeth R, et al. "Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II." ACR open rheumatology vol. 3,1 (2021): 8-16. doi: https://doi.org/10.1002/acr2.11206
Volkmann ER, Steen V, Li N, Roth MD, Clements PJ, Furst DE, Assassi S, Khanna D, Kim GJ, Goldin J, Elashoff RM, Tashkin DP. Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II. ACR Open Rheumatol. 2021 Jan;3(1):8-16. doi: 10.1002/acr2.11206. Epub 2020 Dec 05. PMID: 33277978; PMCID: PMC7811695.
Copy Download .nbib Format: NLM
Showing 157 to 168 of 168 entries